Skip to main content
NIH funding notice RFA-HD-24-005

Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)

Closed on August 7, 2023.

Posted
May 17, 2023
Close date
August 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,204,821 in first-year total cost, median $1,602,411.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-B (50)]2

Most frequent institutions

  1. MAYO CLINIC ROCHESTER1
  2. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under RFA-HD-24-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Partnering for Equity: An Academic and Community Alliance to Eliminate Disparities throughout the Fibroid Experience (PEACE)1P50HD115356-01MARSH, ERICA EWEGIENKA, GANESA REBECCAWILLIAMS, DAVID R.UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$1,619,100ZHD1
2024COllaboration for EQuity in Uterine Leiomyomas1P50HD115283-01STEWART, ELIZABETH AMAYO CLINIC ROCHESTER, MN$1,585,721ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-HD-24-005: Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed) | ScienceDex | ConductScience